Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-10-000009
Filing Date
2010-01-05
Accepted
2010-01-05 15:30:22
Documents
1
Group Members
BAM CAPITAL, LLCBAM MANAGEMENT, LLCHAL MINTZROSS BERMAN

Document Format Files

Seq Description Document Type Size
1 poniard_13ga1.htm SC 13G/A 176455
  Complete submission text file 0000929638-10-000009.txt   178612
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062862501
PONIARD PHARMACEUTICALS, INC. (Subject) CIK: 0000755806 (see all company filings)

EIN.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-40119 | Film No.: 10506458
SIC: 2834 Pharmaceutical Preparations

Mailing Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005
Business Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005 646-307-4503
BAM Opportunity Fund, L.P. (Filed by) CIK: 0001433768 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A